PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 15997532

Consumer response to Clothier.

Consumers for Ethics in Research (CERES)
View original source ↗Export metadata ↓

Abstract

Considering the importance of the subject on which it reported, it is remarkable that there has been so little public discussion of the Clothier report on the ethics of gene therapy. Published last January (see Bulletin 75 for its conclusions and recommendations) it was open for further comment and discussion until May, while the committee has remained in being. There follow three comments on the report, from a consumer group, from a social worker, and from a group of social scientists.

Explore related subjects

Advisory CommitteesCommittee MembershipConsumer OrganizationsEthical ReviewGenetic EngineeringGenetic ResearchGenetic TherapyHumansOrganizational PolicyUnited KingdomBiomedical and Behavioral ResearchClothier Committee (Great Britain)Genetics and ReproductionJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Consumers for Ethics in Research (CERES). 1992. Consumer response to Clothier.. https://pubmed.ncbi.nlm.nih.gov/15997532/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2022

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.

Since the publication of the Revised European-American Classification of Lymphoid Neoplasms in 1994, subsequent updates of the classification of lymphoid neoplasms have been generated through iterative international efforts to achieve broad consensus among hematopathologists, geneticists, molecular scientists, and clinicians. Significant progress has recently been made in the characterization of malignancies of the immune system, with many new insights provided by genomic studies. They have led to this proposal. We have followed the same process that was successfully used for the third and fourth editions of the World Health Organization Classification of Hematologic Neoplasms. The definition, recommended studies, and criteria for the diagnosis of many entities have been extensively refined. Some categories considered provisional have now been upgraded to definite entities. Terminology for some diseases has been revised to adapt nomenclature to the current knowledge of their biology, but these modifications have been restricted to well-justified situations. Major findings from recent genomic studies have impacted the conceptual framework and diagnostic criteria for many disease entities. These changes will have an impact on optimal clinical management. The conclusions of this work are summarized in this report as the proposed International Consensus Classification of mature lymphoid, histiocytic, and dendritic cell tumors.

Advisory Committees↗